1190840-60-8

Basic information

• Product Name: (2S,4R)-1-[1-(2-phenyl-tetrahydro-pyran-4-yl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one
• Synonyms: (2S,4R)-1-[1-(2-phenyl-tetrahydro-pyran-4-yl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one
• CAS NO: 1190840-60-8
• Molecular Weight: 377.486
• Mol File: 1190840-60-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2S,4R)-1-[1-(2-phenyl-tetrahydro-pyran-4-yl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,4R)-1-[1-(2-phenyl-tetrahydro-pyran-4-yl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one(1190840-60-8)
• EPA Substance Registry System: (2S,4R)-1-[1-(2-phenyl-tetrahydro-pyran-4-yl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one(1190840-60-8)

Safety Data

• Hazardous Substances Data: 1190840-60-8(Hazardous Substances Data)

Upstream product

• 20662-53-7 4-(2-keto-1-benzimidazolinyl)piperidine 
• 82110-28-9 (S)-2-phenyl-tetrahydropyran-4-one 
• 147688-62-8 (+/-)-2-phenyl-tetrahydro-2H-pyran-4-one 
• 82065-19-8 2-phenyltetrahydro-2H-pyran-4-ol 
• 100-52-7 benzaldehyde 

Relevant articles and documents

NOVEL PIPERIDINYL-1,3-DIHYDRO-BENZOIMIDAZOL-2-ONES AS M1 AGONISTS

The present invention relates to novel M1 agonistic compounds of the present invention and their use in the treatment of cognitive impairment associated i.a. with schizophrenia and in the treatment of other diseases mediated by the muscarinic M1 receptor.